ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      64,247.97
      2.16%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ID Biomedical - Common Shares (MM) (IDBE)

      7. ID Biomedical - Common Shares (MM) (IDBE) News

      IDBE

      ID Biomedical (IDBE)

      ID Biomedical - Common Shares (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDBE
      DateTimeSourceHeadlineSymbolCompany
      12/08/200510:00AMPR Newswire (US)ID Biomedical announces closing of acquisition by GlaxoSmithKlineNASDAQ:IDBE
      12/06/20058:40PMPR Newswire (US)ID Biomedical announces receipt of court approval for acquisition by GlaxoSmithKlineNASDAQ:IDBE
      12/05/20059:15AMPR Newswire (US)ID Biomedical provides update on application for court approval of acquisition by GlaxoSmithKlineNASDAQ:IDBE
      11/18/20055:06PMPR Newswire (US)ID Biomedical announces rescheduling of court hearing to approve acquisition by GlaxoSmithKlineNASDAQ:IDBE
      11/16/20055:28PMPR Newswire (US)ID Biomedical announces results of securityholders' votes relating to acquisition by GlaxoSmithKlineNASDAQ:IDBE
      11/10/200510:28AMPR Newswire (US)ID Biomedical reports 2005 third quarter resultsNASDAQ:IDBE
      10/24/200510:40AMPR Newswire (US)ID Biomedical Provides Update on Vaccine Development ProgramsNASDAQ:IDBE
      10/20/20057:54PMPR Newswire (US)ID Biomedical announces mailing of meeting materialsNASDAQ:IDBE
      09/07/200512:06PMPR Newswire (US)GlaxoSmithKline To Acquire ID Biomedical CorporationNASDAQ:IDBE
      09/07/200511:31AMPR Newswire (US)GlaxoSmithKline To Acquire ID Biomedical CorporationNASDAQ:IDBEID Biomedical - Common Shares (MM)
      08/15/20055:00PMPR Newswire (US)ID Biomedical reports 2005 second quarter resultsNASDAQ:IDBE
      08/10/20053:10PMPR Newswire (US)ID Biomedical announces 2005 second quarter release date and conference callNASDAQ:IDBE
      07/12/200510:00AMPR Newswire (US)ID Biomedical's flu vaccine granted Fast Track status by FDANASDAQ:IDBE
      05/26/200510:30AMPR Newswire (US)ID Biomedical announces webcast of 2005 Annual General Meeting of ShareholdersNASDAQ:IDBE
      05/20/200511:57AMPR Newswire (US)ID Biomedical announces webcast of 2005 Annual General Meeting of ShareholdersNASDAQ:IDBE
      05/16/20055:00PMPR Newswire (US)ID Biomedical reports 2005 first quarter resultsNASDAQ:IDBE
      05/11/200510:30AMPR Newswire (US)ID Biomedical announces 2005 first quarter release date and conference callNASDAQ:IDBE
      03/30/200510:42AMPR Newswire (US)ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral Clinical Trial in the U.S.NASDAQ:IDBE
      03/22/200510:04AMPR Newswire (US)ID Biomedical receives positive data from clinical testing of its Group-Common Pneumococcal VaccineNASDAQ:IDBE
      03/16/20054:01PMPR Newswire (US)ID Biomedical reports fiscal 2004 year end resultsNASDAQ:IDBE
      03/15/20059:30AMPR Newswire (US)ID Biomedical to pursue U.S. accelerated approval process for its influenza vaccineNASDAQ:IDBE
      03/14/200510:40AMPR Newswire (US)ID Biomedical announces 2004 year end earnings release date and conference callNASDAQ:IDBE
      03/04/20059:30AMPR Newswire (US)ID Biomedical closes sale and leaseback transactionsNASDAQ:IDBE
      01/26/20059:15AMPR Newswire (US)ID Biomedical Announces Immunogenicity Results from Phase II Trial of StreptavaxNASDAQ:IDBE
      01/19/20059:15AMPR Newswire (US)ID Biomedical begins development of pandemic influenza vaccineNASDAQ:IDBE
      01/13/200511:34AMPR Newswire (US)ID Biomedical announces final results from field efficacy trial of its intranasal flu vaccineNASDAQ:IDBE
      01/10/200511:16AMPR Newswire (US)ID Biomedical announces the beginning of a U.S. phase I clinical trial for plague vaccine candidateNASDAQ:IDBE
      01/10/20059:15AMPR Newswire (US)ID Biomedical Closes Financing TransactionNASDAQ:IDBE
      01/10/20059:01AMPR Newswire (US)CSC's DVC Enters Clinical Trial for Plague Vaccine CandidateNASDAQ:IDBEID Biomedical - Common Shares (MM)
      01/07/20059:15AMPR Newswire (US)ID Biomedical receives clearance for Fluviral clinical testing in the U.S.NASDAQ:IDBE
       Showing the most relevant articles for your search:NASDAQ:IDBE